Executive Moves Beacon appoints Dr. Daniel Chung as CMO Closely held Beacon Therapeutics announced the appointment of Dr. Daniel Chung as chief medical officer (CMO), effective immediately. Dr. Chung brings more than three decades of experience in ophthalmology, academic... June 11, 2025